CPT1A facilitates glutamine-independent growth of breast cancer cells by increasing the global lysine succinylation status in cells, especially the succinylation of enolase 1 at K80/81 and K335, which inhibits enolase activity. The gene discussed is ENO1; the disease is breast cancer.